Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

NovoCure Limited (NVCR)

75.6   5 (7.08%) 06-26 18:41
Open: 71.8 Pre. Close: 70.6
High: 75.7 Low: 70.195
Volume: 1,241,862 Market Cap: 7,907(M)
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune Lua for the treatment of malignant pleural mesothelioma. The company also has ongoing or completed clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 75.71 - 75.97 75.97 - 76.21
Low: 69.47 - 69.8 69.8 - 70.09
Close: 75.06 - 75.53 75.53 - 75.97

Technical analysis

as of: 2022-06-24 4:42:03 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 99.89     One year: 116.68
Support: Support1: 67.52    Support2: 56.38
Resistance: Resistance1: 85.52    Resistance2: 99.89
Pivot: 66.65
Moving Average: MA(5): 65.27     MA(20): 70.45
MA(100): 75.82     MA(250): 100.4
MACD: MACD(12,26): -2.7     Signal(9): -3.3
Stochastic oscillator: %K(14,3): 48.6     %D(3): 29.4
RSI: RSI(14): 57.3
52-week: High: 195.77  Low: 56.38
Average Vol(K): 3-Month: 724 (K)  10-Days: 1,310 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ NVCR ] has closed below upper band by 21.9%. Bollinger Bands are 46.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 8 days. This is a sign that the current trend might continue.

Headline News

Sat, 25 Jun 2022
NovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World

Fri, 24 Jun 2022
Maryland State Retirement & Pension System Acquires New Stake in NovoCure Limited (NASDAQ:NVCR) - Defense World

Thu, 23 Jun 2022
Analysts See 36% Gains Ahead For EQAL - Nasdaq

Thu, 23 Jun 2022
Strength Seen in NovoCure (NVCR): Can Its 8% Jump Turn into More Strength? - Nasdaq

Tue, 21 Jun 2022
2022-06-21 | NDAQ:NVCR | Press Release | NovoCure Limited - Stockhouse

Fri, 17 Jun 2022
NovoCure Limited (NASDAQ:NVCR) Director Sells $28331.27 in Stock - Defense World

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 104 (M)
Shares Float 90 (M)
% Held by Insiders 13.4 (%)
% Held by Institutions 79.1 (%)
Shares Short 7,800 (K)
Shares Short P.Month 7,470 (K)

Stock Financials

EPS -0.28
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.98
Profit Margin (%) -11
Operating Margin (%) -8.3
Return on Assets (ttm) -2.5
Return on Equity (ttm) -14.6
Qtrly Rev. Growth 2
Gross Profit (p.s.) 4.05
Sales Per Share 5.18
EBITDA (p.s.) -0.34
Qtrly Earnings Growth 0
Operating Cash Flow 61 (M)
Levered Free Cash Flow 80 (M)

Stock Valuations

PE Ratio -280
PEG Ratio -1.8
Price to Book value 18.99
Price to Sales 14.59
Price to Cash Flow 128.05

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.